Pre-eclampsia is a condition that affects some pregnant women during the second half of their pregnancy. Signs include high blood pressure and protein in the urine. Most cases are mild, but the condition can lead to serious complications for both mother and baby.
Antithrombin alfa is a new drug for the treatment of pre-eclampsia that is given straight into the blood by a drip. It is being studied to see whether it improves the symptoms of pre-eclampsia and if it is safe to use for pregnant women with this disease. If antithrombin alfa is licensed for use in the UK, it could provide a new treatment for pregnant women with pre-eclampsia.
Innovation Observatory Voice
0